Table 5. Follow-up result comparisons between the groups.
| Variable | Improved (n=52) | Nonimproved (n=26) | P value |
|---|---|---|---|
| Echocardiogram | |||
| LVEF (%) | 45.9±7.3 | 36.7±4.3 | <0.001 |
| LVEDD (mm) | 55.1±5.6 | 57.2±7.7 | 0.173 |
| LVESD (mm) | 39.4±4.7 | 44.3±6.7 | <0.001 |
| Ventricular septal thickness (mm) | 10.1±1.6 | 9.5±1.8 | 0.202 |
| LVPWT (mm) | 8.9±1.5 | 8.1±1.7 | 0.030 |
| NYHA grading | 0.019 | ||
| I | 11 (21.2) | 3 (11.5) | |
| II | 32 (61.5) | 12 (46.2) | |
| III | 7 (13.5) | 6 (23.1) | |
| IV | 2 (3.8) | 5 (19.2) | |
| MACCE | 3 (5.8) | 7 (26.9) | <0.001 |
| All-cause mortality | 1 (1.9) | 7 (26.9) | <0.001 |
Data are presented as mean ± standard deviation or number (%). LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic diameter; LVESD, left ventricular end-systolic diameter; LVPWT, left ventricular posterior wall thickness; NYHA, New York Heart Association; MACCE, major adverse cardiovascular and cerebrovascular event.